Is radiotherapy a back up plan after neoadjuvant chemo-immunotherapy in perioperative lung cancer management?
Published on 11 May 2026
Dr Daniel Portik speaks to ecancer about the evolving role of radiotherapy in perioperative lung cancer management.
He details established indications, including stage III and early-stage disease, and discusses emerging adjuvant strategies.
He also addresses real-world challenges and questions the potential for radiotherapy to replace surgery in select cases, emphasising the need for rigorous evaluation of new approaches.